NOT-HL-18-649: NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-18-643 "NHLBI Clinical Ancillary Studies (R01- Clinical Trial Optional)"

NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-18-643 "NHLBI Clinical Ancillary Studies (R01- Clinical Trial Optional)"

Notice Number: NOT-HL-18-649

Key Dates
Release Date: August 28, 2018

Related Announcements
PAR-18-643

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that NHLBI has posted a set of responses to Frequently Asked Questions (FAQs) regarding PAR-18-643 "NHLBI Clinical Ancillary Studies (R01)". The FAQs are available on the NHLBI website at the following link: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/PAR-18-643.

Although not required for application, applicants are strongly encouraged to review the FAQs (which may be updated at any time without additional notice) prior to submitting their application.

Inquiries

Please direct all inquiries to:

Jue Chen, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0550
Email: jue.chen@nih.gov